Human Factor VIII and Factor IX clotting proteins regulatory update

PHAR received U.S. Patent No. 5,919,913 for the purification of human lactoferrin from milk. PHAR is developing lactoferrin as a heparin neutralizer following heart surgery, and as an anti-microbial.

PHAR also received U.S. Patent No. 5,959,738 for the expression in milk of certain fusion proteins. The proteins are used in the production of complex proteins in milk. ...